U.K. advises people with 'significant history' of allergic reactions to skip Pfizer vaccine for now


A day after Britain began its historic COVID-19 vaccination drive, U.K. regulators reported Wednesday that two National Health Service workers given the Pfizer-BioNTech vaccine had experienced allergic reactions and advised other Britons with a "significant history" of allergic reactions to hold off on getting inoculated until they finish investigating the adverse responses. Neither NHS worker was identified, but both carry EpiPen-type adrenaline injectors with them, suggesting they have suffered severe reactions to other allergens.
"As is common with new vaccines, the MHRA [Medicines and Healthcare Products Regulatory Agency] have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination, after two people with a history of significant allergic reactions responded adversely yesterday," said Stephen Powis, the NHS national medical director in England. "Both are recovering well." The Economist's Natasha Loder noted that Pfizer had found a tiny number of allergic reactions in its large clinical trial.
The pamphlet given to people seeking the Pfizer vaccine suggests it should be given to people allergic to any of the substances in the vaccine, adding that "signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
September 28 editorial cartoons
Cartoons Sunday's political cartoons include the Jim Comey indictment and Pam Bondi as a the Wicked Witch of the West
-
Your Party: a Pythonesque shambles
Talking Point Comical disagreements within Jeremy Corbyn and Zarah Sultana's group highlight their precarious position
-
The Liberal Democrats: on the march?
Talking Point After winning their highest number of seats in 2024, can the Lib Dems marry ‘stunts’ with a ‘more focused electoral strategy’?
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year